| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 12.55 M USD | -11.90 M USD | -9.52 M USD | -5.34 M USD | 439000 USD | -731000 USD | -413000 USD | 1.21 M USD | -543180 USD | -14.41 M USD | -9.10 M USD | -7.32 M USD |
| Depreciation & Amortization | 5.22 M USD | 4.22 M USD | 3.17 M USD | 1.29 M USD | 1.33 M USD | 2.08 M USD | 3.14 M USD | 6.59 M USD | 8.41 M USD | 7.24 M USD | 4.89 M USD | 952320 USD |
| Stock-Based Compensation | 2.89 M USD | 4.12 M USD | 2.74 M USD | 2.46 M USD | 2.21 M USD | 1.08 M USD | 515000 USD | 694000 USD | 211809 USD | 522987 USD | 836741 USD | 935316 USD |
| Capital Expenditures | 2.38 M USD | 4.11 M USD | 1.46 M USD | 1.76 M USD | 2.12 M USD | 1.54 M USD | 879000 USD | 624000 USD | 1.64 M USD | 5.83 M USD | 2.26 M USD | 299978 USD |
| Cash Flow from Investing | 7.90 M USD | -3.73 M USD | -24.78 M USD | -1.56 M USD | -1.89 M USD | -1.30 M USD | -544000 USD | -367000 USD | -1.61 M USD | -5.82 M USD | -73.57 M USD | -298352 USD |
| Cash Flow from Financing | -9.57 M USD | 16.07 M USD | 19.69 M USD | 9.02 M USD | 17.50 M USD | -861000 USD | -603000 USD | 3.10 M USD | 2.43 M USD | 16.43 M USD | 84.57 M USD | 9.04 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 10.16 M USD | -16.01 M USD | -10.97 M USD | -7.11 M USD | -1.68 M USD | -2.28 M USD | -1.29 M USD | 588000 USD | -2.18 M USD | -20.24 M USD | -11.36 M USD | -7.62 M USD |
Xtant Medical Holdings Inc. is a leading company in the medical device sector, specializing in the development and distribution of regenerative medicine products and surgical implants. The core purpose of the company is to improve patient outcomes through innovative solutions in orthopedic and neurological surgery. Xtant Medical’s product offerings include biologics and other advanced materials designed to support the healing and repair of tissue, primarily within the spine and broader orthopedics market. Their products are integral in the treatment of complex injuries and conditions, playing a crucial role in both surgical intervention and recovery processes. Based in the healthcare industry, Xtant Medical Holdings Inc. serves hospitals, surgical centers, and clinics, providing essential tools for managing patient care. In the financial market, Xtant's products and innovations position the company as a critical provider within the medical technology landscape, underlining its market presence and influence in advancing medical treatments.